RT Journal Article
SR Electronic
T1 SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20099358
DO 10.1101/2020.05.12.20099358
A1 Bilge Alpaslan Kocamemi
A1 Halil Kurt
A1 Ahmet Sait
A1 Fahriye Sarac
A1 Ahmet Mete Saatci
A1 Bekir Pakdemirli
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099358.abstract
AB Following the announcement of SARS-CoV-2 worldwide pandemic spread by WHO on March 11, 2020, wastewater based epidemiology received great attention in several countries: The Netherlands [Medama et al., 2020; K-Lodder et al., 2020], USA [Wu et al., 2020; Memudryi et al., 2020], Australia [Ahmed et al., 2020], France [Wurtzer et al., 2020], China [Wang et al., 2020], Spain [Randazzo et al., 2020; Walter et al., 2020], Italy (La Rosa et al., 2020; Rimoldi et al., 2020) and Israel [Or et al., 2020], performed analysis in wastewaters by using different virus concentration techniques. Turkey took its place among these countries on 7th of May, 2020 by reporting SARS-CoV-2 RT-qPCR levels at the inlet of seven (7) major municipal wastewater treatment plants (WWTPs) of Istanbul [Alpaslan Kocamemi et al., 2020], which is a metropole with 15.5 million inhabitants and a very high population density (2987 persons/km2) and having about 65 % of Covid-19 cases in Turkey. Sludges that are produced in WWTPs should be expected to contain SARS-CoV-2 virus as well. There has not yet been any study for the fate of SAR-CoV-2 in sludges generated from WWTPs. Knowledge about the existing of SARS-CoV-2 in sludge may be useful for handling the sludge during its dewatering, stabilizing and disposal processes. This information will also be valuable in case of sludges that are used as soil conditioners in agriculture or sent to landfill disposal.In wastewater treatment plants, generally two different types of sludges are generated; primary sludge (PS) and waste activated sludge (WAS). PS forms during the settling of wastewater by gravity in the primary settling tanks. Little decomposition occurs during primary sludge formation. Since most of the inorganic part of the wastewater is removed in the earlier grit removal process, the PS consists of mainly organic material that settles. The PS is about 1-2 % solids by weight. In the biological treatment part of the WWTPs, the biomass that forms in the anaerobic, anoxic and oxic zones of the process is settled in final clarifiers by gravity and returned to the beginning of the biological process so that it is not washed off. The waste activated sludge (WAS) is the excess part of the biomass that grows in this secondary treatment process. It has to be removed from the process not to increase the mixed liquor suspended solids concentration (bacteria concentration) in the secondary process more than a fixed value. The WAS is about 0.6 - 0.9 % solids by weight.This work aims to find whether SARS-CoV-19 is present in the PS and WAS before it is dewatered and sent to anaerobic or aerobic digester processes or to thermal drying operations.For this purpose, on the 7th of May 2020, two (2) PS samples were collected from Ambarliı and Tuzla WWTPs, seven (7) WAS samples were collected from Terkos, Ambarliı, Atakoy I & II, Pasakoy II, Buyukcekmece and Tuzla I WWTPs. Polyethylene glycol 8000 (PEG 8000) adsorption [Wu et al., 2020] SARS-Cov-2 concentration method was used for SARS-CoV-2 concentration after optimization. [Alpaslan Kocamemi et al., 2020]. Real time RT-PCR diagnostic panel validated by US was used to quantify SARS-CoV-2 RNA in primary and waste activated sludge samples taken from WWTPs in Istanbul. All samples were tested positive. Titers of SARS-CoV-2 have been detected ranging copies between 1.17×104 to 4.02×104 per liter.Value of the DataThe dataset provides information about SARS-CoV-19 in primary and waste activated sludges generated in WWTPs.As being the first study in the world, the dataset presented is expected to be beneficial in handling the sludge during its dewatering, stabilizing and disposal processesData Description SARS-CoV-2 copy numbers per liter measured for sludge samples from WWTPs were summarized in Table 1 and shown in Figure 1 together with SARS-CoV-2 copy numbers observed in an earlier study [Alpaslan Kocamemi et al., 2020] in the influent of the WWTPs from which the sludge samples were taken.To the best of our knowledge, no study has yet been reported the presence of SARS-CoV-2 in primary sludge (PS) and waste activated sludge (WAS) samples. Herein we report the results of SARS-CoV-2 presence in two (2) PS and seven (7) WAS samples from WWTPs in Istanbul. A total of nine (9) sludge samples were collected on the 7th May of 2020 and investigated for presence of SARS-CoV-2 with RT-qPCR methodology. SARS-CoV-2 genome was detected quantitatively from all samples. Sludge samples presented CT ranging from 33.5 to 35.8. Titers of SARS-CoV-2 have been detected ranging from 1.17×104 to 4.02×104 per liter.The detected numbers of SARS-CoV-2 in PS samples were found similar to those observed for WAS samples. SARS-CoV-2 copy numbers detected in PS and WAS on 7th of May, 2020 are greater than the copy numbers observed in the influent of these WWTPs on 21st April, 2020 [Alpaslan Kocamemi, 2020]. By considering the fact that the number of cases reported for Istanbul on the 7th of May, 2020 is less than the cases reported for the 21st April, 2020, it may be concluded that SARS-CoV-2 concentrations are more in both primary and waste activated sludge.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financed by Republic of Turkey, Ministry of Agriculture and Forestry.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article.